Annual Masterclass Video and Photo Gallery
MPE Masterclass 2024
Myeloma Patients Europe (MPE) held our Masterclass 2024 in Madrid, Spain, from the 3rd to the 5th of May, 2024. Sessions covered the most relevant topics for patient organisations like treatment, side effects, young myeloma patients and much more.
Take a look at the photo gallery from the weekend event. The images will automatically play, but you can click on any of the photos to make them bigger and play them manually.Â
Â
MPE Masterclass 2023
Masterclass 2023 | CAR-T updates, challenges, and the future
![Masterclass 2023 | CAR-T updates, challenges, and the future](https://i.ytimg.com/vi/3lSjE9wtAuA/maxresdefault.jpg)
![Masterclass 2023 | Myeloma and AL amyloidosis treatment updates](https://i.ytimg.com/vi/xiehSpImm_s/maxresdefault.jpg)
![Masterclass 2023 | Health Technology Assessment (HTA)](https://i.ytimg.com/vi/kQlOWowrm94/maxresdefault.jpg)
![Masterclass 2023 | Running effective Facebook support groups](https://i.ytimg.com/vi/AEtWRIEKYlg/maxresdefault.jpg)
![Masterclass 2023 | Fundraising for patient organisations](https://i.ytimg.com/vi/ooIFwFVn9LQ/maxresdefault.jpg)
![Masterclass 2023 | Panel discussion on sequencing: Optimising the myeloma Pathway](https://i.ytimg.com/vi/b0uDOWKv83g/mqdefault.jpg)
Speakers:
Dr. Charlotte Pawlyn, PhD, Haematologist and Clinician Scientist, ...The Institute of Cancer Research, London
Prof. Dr. Roman Hajek, Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
Prof. Carole Longson, Independent Senior Adviser, Life Science Policy, HTA and Market Access
Tanja Podkonjak, Director of Access and Reimbursement Policy, Takeda EUCAN Oncology and Steering Committee member of EFPIA’s Oncology Platform[+] Show More
![Masterclass 2023 | Importance of physical fitness for myeloma and AL amyloidosis patients](https://i.ytimg.com/vi/i5A5QF-3SGo/mqdefault.jpg)
![Masterclass 2023 | Improving access to clinical trials in Central Eastern European (CEE) countries](https://i.ytimg.com/vi/tiuQrTWtXy0/maxresdefault.jpg)
![Masterclass 2023 | Press relation and media engagement](https://i.ytimg.com/vi/8ynhJImDZNI/mqdefault.jpg)
Take a look at the photo gallery from the weekend event. The images will automatically play, but you can click on any of the photos to make them bigger and play them manually.Â
MPE Masterclass 2022
After two years of virtual Masterclasses, Myeloma Patients Europe (MPE) held our Masterclass 2022 in Amsterdam, The Netherlands, between 1 and 3 July 2022. Sessions covered the most relevant topics for patient organisations on treatment, access and quality of life. Each speaker summarised their talks, explaining the most important points covered in each session. Watch the videos in the gallery below.
We also celebrated our 10th anniversary, which had to be cancelled last year due to the covid pandemic.
Watch below the recordings of the presentations given on the 2nd and 3rd July 2022
MPE Masterclass 2022 | Myeloma treatment updates
![MPE Masterclass 2022 | Myeloma treatment updates](https://i.ytimg.com/vi/D0JqC68GJp4/maxresdefault.jpg)
![MPE Masterclass 2022 | What role does transplantation still play in the treatment of myeloma?](https://i.ytimg.com/vi/l8OXGyMLcY4/maxresdefault.jpg)
![MPE Masterclass 2022 | Living well with Myeloma](https://i.ytimg.com/vi/h1YH0VYEki8/maxresdefault.jpg)
![MPE Masterclass 2022 | Latest updates on COVID-19 and its impact on myeloma patients](https://i.ytimg.com/vi/wPgoAm468M8/maxresdefault.jpg)
![MPE Masterclass 2022 | Diagnosis and management of AL amyloidosis](https://i.ytimg.com/vi/kGcjyQEewjM/maxresdefault.jpg)
![MPE Masterclass 2022 | Having myeloma or AL amyloidosis while having a job](https://i.ytimg.com/vi/5rtv98QilbQ/maxresdefault.jpg)
![MPE Masterclass 2022 | Patient group involvement in HTA](https://i.ytimg.com/vi/LpHv_STv72c/mqdefault.jpg)
![MPE Masterclass 2022 Highlight reel](https://i.ytimg.com/vi/kbJ253ShxXA/maxresdefault.jpg)
MPE Masterclass 2021
The MPE Masterclass 2021 was held virtually and included lectures on myeloma and AL amyloidosis diagnosis and treatment, discussions on access challenges across Europe, presentations on the impact of COVID-19 on the patient community, and workshops to support the capacity of patient organizations.
Watch below the recordings of the presentations given on the 2nd and 3rd July 2021.
MPE Masterclass 2021 | Welcome message
![MPE Masterclass 2021 | Welcome message](https://i.ytimg.com/vi/33DUVXp8N6s/maxresdefault.jpg)
![MPE Masterclass - A welcome message from Dr MarÃa Victoria Mateos](https://i.ytimg.com/vi/50MBN37PR88/maxresdefault.jpg)
![MPE Masterclass - A welcome message from Dr Mohamad Mohty](https://i.ytimg.com/vi/3vJE1JUybK0/maxresdefault.jpg)
![MPE Masterclass 2021 | The early detection and diagnosis of MGUS and SMM](https://i.ytimg.com/vi/FXRP8-2BVAk/maxresdefault.jpg)
Check all the sessions included in the MPE Masterclass 2021 here: https://www.mpeurope.org/what-we-do/programmes/annual-masterclass-and-annual-general-meeting/annual-masterclass-video-gallery[+] Show More
![MPE Masterclass 2021 | Immunotherapy in the treatment of myeloma and AL amyloidosis](https://i.ytimg.com/vi/p1QZ-1nZDY0/maxresdefault.jpg)
Check all the sessions included in the MPE Masterclass 2021 here: https://www.mpeurope.org/what-we-do/programmes/annual-masterclass-and-annual-general-meeting/annual-masterclass-video-gallery[+] Show More
![Masterclass 2021 | COVID 19 and the effect on the treatment for myeloma and AL amyloidosis patients](https://i.ytimg.com/vi/1_lvKMtdybg/maxresdefault.jpg)
Check all the sessions included in the MPE Masterclass 2021 here: https://www.mpeurope.org/what-we-do/programmes/annual-masterclass-and-annual-general-meeting/annual-masterclass-video-gallery[+] Show More
![MPE Masterclass 2021 | New developments and controversies in the myeloma treatment pathway](https://i.ytimg.com/vi/tUhzEg7SBxw/maxresdefault.jpg)
Check all the sessions included in the MPE Masterclass 2021 here: https://www.mpeurope.org/what-we-do/programmes/annual-masterclass-and-annual-general-meeting/annual-masterclass-video-gallery[+] Show More
![MPE Masterclass 2021 |Developments in AL amyloidosis diagnostic centres of expertise](https://i.ytimg.com/vi/rTm-PdAVoMI/maxresdefault.jpg)
![MPE Masterclass 2021 | Palliative Care and quality of life](https://i.ytimg.com/vi/xfiQeIM2llQ/maxresdefault.jpg)
Check all the sessions ...included in the MPE Masterclass 2021 here: https://www.mpeurope.org/what-we-do/programmes/annual-masterclass-and-annual-general-meeting/annual-masterclass-video-gallery[+] Show More
![MPE Masterclass 2021 | MPE members response to and resiliency during COVID 19. Poland](https://i.ytimg.com/vi/vnsbc3-tWi4/mqdefault.jpg)
Check all the sessions included in the MPE Masterclass 2021 here: https://www.mpeurope.org/what-we-do/programmes/annual-masterclass-and-annual-general-meeting/annual-masterclass-video-gallery[+] Show More
![MPE Masterclass 2021 | MPE members response to and resiliency during COVID 19. Israel](https://i.ytimg.com/vi/rBykL7t9A-A/maxresdefault.jpg)
Check all the sessions included in the MPE Masterclass 2021 here: https://www.mpeurope.org/what-we-do/programmes/annual-masterclass-and-annual-general-meeting/annual-masterclass-video-gallery[+] Show More
![MPE Masterclass 2021 | Panel discussion on Minimal Residual Disease (MRD). Hans Scheurer](https://i.ytimg.com/vi/oQnGs64QDfg/maxresdefault.jpg)
Check all the sessions included in the MPE Masterclass 2021 here: https://www.mpeurope.org/what-we-do/programmes/annual-masterclass-and-annual-general-meeting/annual-masterclass-video-gallery[+] Show More
Annual Masterclass 2020
MPE AGM 2020 - Webinar on Myeloma and AL amyloidosis treatment updates
This webinar is part of the webinars series planned to replace the Masterclass included in the MPE Annual General Meeting (AGM) 2020, which was cancelled due to the outbreak of the coronavirus infection.[+] Show More
![MPE AGM 2020 - Webinar on Myeloma and AL amyloidosis treatment updates](https://i.ytimg.com/vi/9TerYDBJTRM/mqdefault.jpg)
This webinar is part of the webinars series planned to replace the Masterclass included in the MPE Annual General Meeting (AGM) 2020, which was cancelled due to the outbreak of the coronavirus infection.[+] Show More
![MPE AGM 2020 - Webinar on reimbursement and Health Technology Assessment (HTA) in Europe](https://i.ytimg.com/vi/LG26T9wbcSA/maxresdefault.jpg)
![MPE AGM2020 webinar series - Big data, the Harmony example](https://i.ytimg.com/vi/uv4Qz25B3cU/mqdefault.jpg)
![Watch the webinar on personalised medicines in myeloma and AL amyloidosis](https://i.ytimg.com/vi/qVidOE5eZKE/mqdefault.jpg)
This webinar is part of an educational programme planned to replace the Masterclass included in the MPE Annual General Meeting (AGM), which was cancelled due to the outbreak of the coronavirus infection.[+] Show More
![Minimal Residual Disease (MRD) in myeloma and related diseases](https://i.ytimg.com/vi/hmhE5D6VEjE/mqdefault.jpg)
![Webinar on the impact of myeloma and AL amyloidosis in carers](https://i.ytimg.com/vi/8EwYg826Hzo/maxresdefault.jpg)
This webinar is part of an educational programme planned to replace the Masterclass included in the MPE Annual General Meeting (AGM), which was cancelled due to the outbreak of the coronavirus infection.[+] Show More
Annual Masterclass 2019
MPE AGM 2019 outtakes
![MPE AGM 2019 outtakes](https://i.ytimg.com/vi/-1qfJzWcnXY/maxresdefault.jpg)
![Myeloma Treatment Updates](https://i.ytimg.com/vi/KSgtVgyktsE/maxresdefault.jpg)
![Surrogate end-points in myeloma and AL amyloidosis](https://i.ytimg.com/vi/VzjiRMlFZRM/maxresdefault.jpg)
![Measuring and utilising quality of life](https://i.ytimg.com/vi/f06wm8MmhbU/maxresdefault.jpg)
![AL Amyloidosis](https://i.ytimg.com/vi/fla8lDDneBQ/maxresdefault.jpg)
![The role of CAR-T](https://i.ytimg.com/vi/jmpY5xrHPGI/mqdefault.jpg)
MPE AGM 2019 photo gallery
Annual Masterclass 2018
MPE Capacity Building Programme
![MPE Capacity Building Programme](https://i.ytimg.com/vi/se7Nnn02B14/maxresdefault.jpg)
![Community Advisory Boards and case studies of MPE member groups](https://i.ytimg.com/vi/hGOdLFNeCSw/maxresdefault.jpg)
![Rehabilitation, self-care and quality of life](https://i.ytimg.com/vi/oP6hReW0KxU/maxresdefault.jpg)
![Journey to a professional and empowered advocate](https://i.ytimg.com/vi/IWtM3PNTKt4/maxresdefault.jpg)
![Clinical trials design and study endpoints](https://i.ytimg.com/vi/1jnYpJYZK-c/maxresdefault.jpg)
![Myeloma related diseases](https://i.ytimg.com/vi/1BklCTNdNmo/maxresdefault.jpg)
![Drug access and affordability](https://i.ytimg.com/vi/LUVGQdDfqU4/maxresdefault.jpg)
![Coping with a chronic disease](https://i.ytimg.com/vi/3sThuayxyM4/maxresdefault.jpg)
![Update on diagnosis and treatment of AL amyloidosis](https://i.ytimg.com/vi/LgkgFAQJ9yE/maxresdefault.jpg)
Annual Masterclass 2017
playlistId
parameter cannot be found. : playlistNotFoundAnnual Masterclass 2016
MPE Capacity Building Programme
![MPE Capacity Building Programme](https://i.ytimg.com/vi/se7Nnn02B14/maxresdefault.jpg)
![Community Advisory Boards and case studies of MPE member groups](https://i.ytimg.com/vi/hGOdLFNeCSw/maxresdefault.jpg)
![Rehabilitation, self-care and quality of life](https://i.ytimg.com/vi/oP6hReW0KxU/maxresdefault.jpg)
![Journey to a professional and empowered advocate](https://i.ytimg.com/vi/IWtM3PNTKt4/maxresdefault.jpg)
![Clinical trials design and study endpoints](https://i.ytimg.com/vi/1jnYpJYZK-c/maxresdefault.jpg)
![Myeloma related diseases](https://i.ytimg.com/vi/1BklCTNdNmo/maxresdefault.jpg)
![Drug access and affordability](https://i.ytimg.com/vi/LUVGQdDfqU4/maxresdefault.jpg)
![Coping with a chronic disease](https://i.ytimg.com/vi/3sThuayxyM4/maxresdefault.jpg)
![Update on diagnosis and treatment of AL amyloidosis](https://i.ytimg.com/vi/LgkgFAQJ9yE/maxresdefault.jpg)